Welcome to CKB CORE's new home! Please be sure to update any bookmarks you may have.
×

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03979066
Title Study Evaluating NEOadjuvant Immunotherapy in Resectable PANCreatic Ductal Adenocarcinoma (NEOiPANC)
Acronym NEOiPANC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gulam Manji
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.